RUSSIA TO START PRELIMINARY TRIALS OF AVIIFAVIR – COVID-19

Highlights –

• Russia got approval for its anti-influenza drug, Aviifavir to treat COVID-19.
• RDIF provided funds for the development and production of the drug.
• The first stage of the clinical trial involves 330 patients and is ongoing.
• Russia has the third-highest number of confirmed COVID-19 cases in the world.

In a recent update on the new coronavirus....